First medication for common liver inflammation approved by FDA
The approval of the first NASH medication signifies a critical milestone in addressing the unmet medical needs of patients grappling with this complex condition. Until now, treatment options for NASH primarily focused on lifestyle modifications, such as dietary changes and increased physical activity, aimed at mitigating risk factors like obesity and insulin resistance. However, such … Read more